|Articles|August 22, 2018
Innovative and Robust Analytical Technologies to Address Key Challenges of Critical Quality Attributes Monitoring in Biopharmaceutical Development
Author(s)Agilent Technologies
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
CDC Revises Childhood Immunization Schedule, Shifting Demand Dynamics
2
New AI Oncology Alliance Highlights Industry Push for Scalable Genomics
3
Industry Outlook 2026: Biopharma Braces for Economic Upheaval While Eyeing AI-Driven Transformation (Part 1)
4
What Are the Benefits of Single-Use in CGT Manufacturing?
5